Resplice Autism Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 2 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About Resplice Autism Research Foundation
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Srikanth Bejagam and Chandrashekhar Thodupunuri serve as directors at the Company.
- CIN/LLPIN
U73100TG2022NPL168206
- Company No.
168206
- Company Classification
Private Not For Profit Company
- Incorporation Date
13 Nov 2022
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Resplice Autism Research Foundation?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srikanth Bejagam | Director | 13-Nov-2022 | Current |
Chandrashekhar Thodupunuri | Director | 13-Nov-2022 | Current |
Financial Performance of Resplice Autism Research Foundation.
Enhance accessibility to Resplice Autism Research Foundation's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Resplice Autism Research Foundation?
Unlock access to Resplice Autism Research Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Providence Microbiome Research Center Private LimitedActive 4 years 4 months
Chandrashekhar Thodupunuri is a mutual person
- Serendipity Centre For Community Health Private LimitedActive 29 years 7 months
Srikanth Bejagam and Chandrashekhar Thodupunuri are mutual person
- Gutsy Medical Sciences Private LimitedActive 9 months 29 days
Chandrashekhar Thodupunuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Resplice Autism Research Foundation?
Resplice Autism Research Foundation has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Resplice Autism Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Resplice Autism Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.